AKT1 and breast carcinoma: For example, overexpression of PPAR-δ was shown to improve breast cancer cell survival during low-glucose or hypoxic cell culture conditions through multiple mechanisms (e.g., enhanced antioxidant signaling, AKT/protein kinase B activation), and increased cell survival was inhibited with PPAR-δ antagonists [47].